The breaking of immune tolerance against autologous angiogenic endothelial cells should be a useful approach for cancer therapy. Here we show that immunotherapy of tumors using fixed xenogeneic whole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback